Šušnjar S - Search Results

1

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).

Castelo-Branco L, Tsourti Z, Gennatas S, Rogado J, Sekacheva M, Viñal D, Lee R, Croitoru A, Vitorino M, Khallaf S, Šušnjar S, Soewoto W, Cardeña A, Djerouni M, Rossi M, Alonso-Gordoa T, Ngelangel C, Whisenant JG, Choueiri TK, Dimopoulou G, Pradervand S, Arnold D, Harrington K, Michielin O, Dafni U, Pentheroudakis G, Peters S, Romano E. Castelo-Branco L, et al. Among authors: susnjar s. ESMO Open. 2022 Jun;7(3):100499. doi: 10.1016/j.esmoop.2022.100499. Epub 2022 May 8. ESMO Open. 2022. PMID: 35644101 Free PMC article.

2

Tumor response and patient outcome after preoperative radiotherapy in locally advanced non-inflammatory breast cancer patients.

Mladenovic J, Susnjar S, Tanic M, Jankovic R, Karadzic K, Gavrilovic D, Stojanovic S, Plesinac-Karapandzic V. Mladenovic J, et al. Among authors: susnjar s. J BUON. 2017 Mar-Apr;22(2):325-333. J BUON. 2017. PMID: 28534352 Free article.

3

The influence of PTEN protein expression on disease outcome in premenopausal hormone receptor-positive early breast cancer patients treated with adjuvant ovarian ablation: a long-term follow-up.

Ursulovic T, Milovanovic Z, Medic-Milijic N, Gavrilovic D, Plesinac-Karapandzic V, Susnjar S. Ursulovic T, et al. Among authors: susnjar s. J BUON. 2018 Jul-Aug;23(4):902-909. J BUON. 2018. PMID: 30358192 Free article.

4

The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.

Stamatovic L, Susnjar S, Gavrilovic D, Minic I, Ursulovic T, Dzodic R. Stamatovic L, et al. Among authors: susnjar s. J BUON. 2018 Sep-Oct;23(5):1273-1280. J BUON. 2018. PMID: 30570847 Free article.

5

Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients.

Uzelac B, Krivokuca A, Susnjar S, Milovanovic Z, Supic G. Uzelac B, et al. Among authors: susnjar s. Genet Test Mol Biomarkers. 2021 Mar;25(3):227-235. doi: 10.1089/gtmb.2020.0138. Genet Test Mol Biomarkers. 2021. PMID: 33734898

6

The influence of steroid receptors status on disease outcome in early breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil chemotherapy.

Susnjar S, Kezić I, Nesković-Konstantinović Z, Gavrilović D, Nikolić-Vukosavljević D. Susnjar S, et al. J BUON. 2005 Jul-Sep;10(3):385-91. J BUON. 2005. PMID: 17357194

7

Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer.

Colaković S, Lukiç V, Mitroviç L, Jeliç S, Susnjar S, Marinkoviç J. Colaković S, et al. Among authors: susnjar s. Int J Biol Markers. 2000 Apr-Jun;15(2):147-52. doi: 10.1177/172460080001500204. Int J Biol Markers. 2000. PMID: 10883888 Free article.

8

Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.

Tanić M, Krivokuća A, Čavić M, Mladenović J, Plesinac Karapandžić V, Beck S, Radulović S, Susnjar S, Janković R. Tanić M, et al. Among authors: susnjar s. Radiat Oncol. 2018 Oct 1;13(1):193. doi: 10.1186/s13014-018-1129-4. Radiat Oncol. 2018. PMID: 30285791 Free PMC article.

9

Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.

Krivokuca A, Mihajlovic M, Susnjar S, Spasojevic IB, Minic I, Popovic L, Brankovic-Magic M. Krivokuca A, et al. Among authors: susnjar s. Curr Probl Cancer. 2022 Feb;46(1):100767. doi: 10.1016/j.currproblcancer.2021.100767. Epub 2021 Jul 10. Curr Probl Cancer. 2022. PMID: 34284872

10

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.

Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters